Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RESTORE II Trial: Safety & Performance Study of the ReZolve2 Sirolimus-Eluting Bioresorbable Coronary Scaffold

NCT01845311 is registered in ClinicalTrials.gov with REVA Medical, Inc. as lead sponsor.

NCT NCT01845311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01845311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RESTORE II Trial: Safety & Performance Study of the ReZolve2 Sirolimus-Eluting Bioresorbable Coronary Scaffold
Lead sponsor
REVA Medical, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2013
Completion date
January 31, 2019
Enrollment
89 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, coronary artery stenosis